Radius Health. has been granted a patent for estrogen receptor modulators, including specific compounds and pharmaceutical compositions. These modulators are intended for treating diseases related to estrogen receptors, either alone or in combination with other treatments. GlobalData’s report on Radius Health gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Radius Health, Microneedles for transdermal drug delivery was a key innovation area identified from patents. Radius Health's grant share as of June 2024 was 37%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US12018019B2 outlines a series of claims related to specific chemical compounds, particularly those characterized by a defined structural formula. The primary claim (Claim 1) introduces a compound represented by formula I', with subsequent claims detailing variations in the chemical structure, including specific substituents and configurations. Notably, claims 2 through 10 specify particular arrangements of atoms and functional groups, such as the presence of ethylamino and cyclopropylmethyl groups, as well as various halogen and alkyl substituents. Claim 11 lists several specific compounds that fall under the broader category defined in Claim 1, emphasizing their potential applications in pharmaceutical formulations.
Additionally, the patent includes claims related to the therapeutic use of these compounds. Claim 12 describes a pharmaceutical composition that combines the compounds with acceptable excipients, while Claims 13 and 14 outline methods for treating conditions associated with estrogen levels and various types of cancer, respectively. These claims suggest that the compounds may be effective in addressing diseases linked to hormonal imbalances and specific malignancies, indicating their potential utility in medical treatments. The patent thus encompasses both the chemical composition of the compounds and their applications in therapeutic contexts.
To know more about GlobalData’s detailed insights on Radius Health, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
